Niki BioSolutions, Inc.
Nasdaq · Technology · Measuring & Controlling Devices, Nec · Princeton, NJ
NIKI chart
What traders are saying about $NIKI
Latest postsNiki BioSolutions, Inc. news
- Niki BioSolutions receives New York approval for expanded APOE test
Investing.com ·
- Niki BioSolutions gets NY approval to expand APOE test specimen types
StreetInsider ·
- Niki BioSolutions expands APOE genotyping test approval to dried blood spots, plasma, and urine in New York.
Pluang ·
- Niki BioSolutions’ DiamiR Biosciences Wins NYSDOH CLEP Approval to Expand APOE Genotyping Test Specimen Types
Quiver Quantitative ·
- Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine
Yahoo Finance ·
- Niki BioSolutions signs APOE testing deal with Charter Research
Investing.com ·
- Niki BioSolutions signs APOE testing deal with Charter Research By Investing.com
Investing.com Nigeria ·
- Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research
Yahoo Finance ·
- Niki BioSolutions to supply APOE genotyping for Alzheimer’s clinical trials at Charter Research sites
Pluang ·
- Form 4 Niki BioSolutions: Laura A. Philips (Director) For: 22 July
Investing.com Australia ·
- Niki BioSolutions’ Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation’s “Rett Research Tool Belt” Series
Yahoo Finance ·
- Niki BioSolutions Partners with Global Alzheimer’s Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002
Yahoo Finance ·
Niki BioSolutions, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $431,378 | $1.3M |
| Net income | -$1.4M | -$4.3M | -$2.8M | -$9.8M |
| Diluted EPS | $-0.19 | $-0.78 | $-0.62 | $-2.75 |
| Total assets (year end) | $18.7M | $16.1M | $20.6M | $20.9M |
| Cash and equivalents (year end) | $3.5M | $874,238 | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Niki BioSolutions, Inc.
- Ticker
- NIKI (Nasdaq)
- Industry
- Measuring & Controlling Devices, Nec
- Headquarters
- Princeton, NJ
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1734005
- Former names
- Aptorum Group Ltd
Frequently asked questions
What exchange is Niki BioSolutions, Inc. listed on?
Niki BioSolutions, Inc. trades on the Nasdaq under the ticker symbol NIKI.
What industry is Niki BioSolutions, Inc. in?
Niki BioSolutions, Inc. is classified by the SEC under "Measuring & Controlling Devices, Nec", part of the Technology sector on StockTweeting.
Where is Niki BioSolutions, Inc. headquartered?
Niki BioSolutions, Inc.'s business address on file with the SEC is in Princeton, NJ.
When does Niki BioSolutions, Inc.'s fiscal year end?
Niki BioSolutions, Inc.'s fiscal year ends on December 31.
How much revenue did Niki BioSolutions, Inc. report?
Niki BioSolutions, Inc. reported $431,378 in revenue for calendar year 2023, according to its SEC filings.